本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Anaptysbio Inc

53.87
-1.2900-2.34%
盤後53.870.00000.00%19:30 EDT
成交量:33.62萬
成交額:1,832.90萬
市值:15.95億
市盈率:-59.54
高:56.32
開:55.43
低:53.75
收:55.16
52周最高:73.30
52周最低:17.11
股本:2,960.85萬
流通股本:2,104.51萬
量比:0.55
換手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-0.9047
每股收益(LYR):-0.4601
淨資產收益率:-114.55%
總資產收益率:6.78%
市淨率:125.13
市盈率(LYR):-117.08

資料載入中...

2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

重要事件披露

8-K - Current report
2021/01/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report